The PROOF Trial - Prospective, Open-label, Multicenter, Non-randomized Investigation on Percutaneous Patent Foramen Ovale (PFO) Closure Using the Occlutech PFO Occluder to Prevent Recurrence of Stroke in Patients With Cryptogenic Stroke and High Risk PFO
Clinical trial NCT04029233 · TERMINATED
Trial details
- NCT number
- NCT04029233
- Sponsor
- Occlutech International AB
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2019-10-03
- Primary completion
- 2024-04-16
- Enrollment
- 582
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.